Atlas Trials

Efficacy and Safety of Ustekinumab in Bullous Pemphigoid

Clinical trial NCT04117932 · COMPLETED

Trial details

NCT number
NCT04117932
Sponsor
CHU de Reims
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bullous Pemphigoid
Start date
2020-03-11
Primary completion
2022-12-22
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.